Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China

Fig. 3

Kaplan–Meier curves for (a) DOR among responders, (b) time to response among responders, (c) estimated FFS in the mITT population, and (d) OS in the mITT population. DOR was defined as the time from the first assessment of CR or PR to the first detection of a lack of response. If the patient experienced progression from CR or PR to a lack of response for more than one time, the cumulative DOR was recorded. CR complete response, DOR duration of response, FSS failure-free survival, mITT modified intent-to-treat, OS overall survival, PR partial response

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us